首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Corticotropin-releasing Factor-1 Receptor Involvement In Behavioral Neuroadaptation To Ethanol: A Urocortin_1-independent Mechanism
【24h】

Corticotropin-releasing Factor-1 Receptor Involvement In Behavioral Neuroadaptation To Ethanol: A Urocortin_1-independent Mechanism

机译:促肾上腺皮质激素释放因子-1受体参与对乙醇的行为神经适应:Urocortin_1独立机制。

获取原文
获取原文并翻译 | 示例
       

摘要

A common expression of neuroadaptations induced by repeated exposure to addictive drugs is a persistent sensitized behavioral response to their stimulant properties. Neuroplasticity underlying drug-induced sensitization has been proposed to explain compulsive drug pursuit and consumption characteristic of addiction. The hypothalamic-pituitary-adrenal (HPA) axis-activating neuropep-tide, corticotropin-releasing factor (CRF), may be the keystone in drug-induced neuroadaptation. Cortkosterone-activated glucocor-ticoid receptors (GRs) mediate the development of sensitization to ethanol (EtOH), implicating the HPA axis in this process. EtOH-induced increases in corticosterone require CRF activation of CRF_1 receptors. We posited that CRF_1 signaling pathways are crucial for EtOH-induced sensitization. We demonstrate that mice lacking CRF_1 receptors do not show psychomotor sensitization to EtOH, a phenomenon that was also absent in CRF_(1+2) receptor double-knockout mice. Deletion of CRF_2 receptors alone did not prevent sensitization. A blunted endocrine response to EtOH was found only in the genotypes showing no sensitization. The CRF_1 receptor antagonist CP-154,526 attenuated the acquisition and prevented the expression of EtOH-induced psychomotor sensitization. Because CRF_1 receptors are also activated by urocortin-1 (Ucn_1), we tested Ucn_1 knockout mice for EtOH sensitization and found normal sensitization in this genotype. Finally, we show that the GR antagonist mifepristone does not block the expression of EtOH sensitization. CRF and CRF_1 receptors, therefore, are involved in the neurobiological adaptations that underlie the development and expression of psychomotor sensitization to EtOH. A CRF/CRF_1-mediated mechanism involving the HPA axis is proposed for acquisition, whereas an extrahypothalamic CRF/CRF, participation is suggested for expression of sensitization to EtOH.
机译:反复接触成瘾性药物引起的神经适应的常见表达是对其兴奋性的持续敏感行为反应。已经提出了药物诱导的致敏作用的神经可塑性来解释强迫性药物的追求和成瘾的消费特征。下丘脑-垂体-肾上腺(HPA)轴激活神经肽,促肾上腺皮质激素释放因子(CRF),可能是药物诱导的神经适应的关键。肾上腺皮质激素激活的糖皮质激素受体(GRs)介导对乙醇(EtOH)致敏的发展,在此过程中牵涉HPA轴。 EtOH引起的皮质酮增加需要CRF激活CRF_1受体。我们假设CRF_1信号通路对于EtOH致敏至关重要。我们证明了缺少CRF_1受体的小鼠没有表现出对EtOH的精神运动敏化,这种现象在CRF_(1 + 2)受体双敲除小鼠中也不存在。单独删除CRF_2受体并不能防止过敏。仅在未显示致敏作用的基因型中发现对EtOH的内分泌反应迟钝。 CRF_1受体拮抗剂CP-154,526减弱了这种获取,并阻止了EtOH诱导的精神运动敏化的表达。因为CRF_1受体也被urocortin-1(Ucn_1)激活,所以我们测试了敲除Ucn_1的小鼠的EtOH致敏作用,并发现了该基因型的正常致敏作用。最后,我们证明了GR拮抗剂米非司酮不会阻断EtOH致敏的表达。因此,CRF和CRF_1受体参与了神经生物学适应,这是对EtOH产生精神运动敏化作用的基础。提出了一种涉及HPA轴的CRF / CRF_1介导的机制,而建议使用下丘脑CRF / CRF参与表达对EtOH的致敏作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号